» Articles » PMID: 10380116

3-Thia Fatty Acid Treatment, in Contrast to Eicosapentaenoic Acid and Starvation, Induces Gene Expression of Carnitine Palmitoyltransferase-II in Rat Liver

Overview
Journal Lipids
Specialty Biochemistry
Date 1999 Jun 24
PMID 10380116
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to investigate the hepatic regulation and beta-oxidation of long-chain fatty acids in peroxisomes and mitochondria, after 3-thia- tetradecylthioacetic acid (C14-S-acetic acid) treatment. When palmitoyl-CoA and palmitoyl-L-carnitine were used as substrates, hepatic formation of acid-soluble products was significantly increased in C14-S-acetic acid treated rats. Administration of C14-S-acetic acid resulted in increased enzyme activity and mRNA levels of hepatic mitochondrial carnitine palmitoyltransferase (CPT)-II. CPT-II activity correlated with both palmitoyl-CoA and palmitoyl-L-carnitine oxidation in rats treated with different chain-length 3-thia fatty acids. CPT-I activity and mRNA levels were, however, marginally affected. The hepatic CPT-II activity was mainly localized in the mitochondrial fraction, whereas the CPT-I activity was enriched in the mitochondrial, peroxisomal, and microsomal fractions. In C14-S-acetic acid-treated rats, the specific activity of peroxisomal and microsomal CPT-I increased, whereas the mitochondrial activity tended to decrease. C14-S-Acetyl-CoA inhibited CPT-I activity in vitro. The sensitivity of CPT-I to malonyl-CoA was unchanged, and the hepatic malonyl-CoA concentration increased after C14-S-acetic acid treatment. The mRNA levels of acetyl-CoA carboxylase increased. In hepatocytes cultured from palmitic acid- and C14-S-acetic acid-treated rats, the CPT-I inhibitor etomoxir inhibited the formation of acid-soluble products 91 and 21%, respectively. In contrast to 3-thia fatty acid treatment, eicosapentaenoic acid treatment and starvation increased the mitochondrial CPT-I activity and reduced its malonyl-CoA sensitivity. Palmitoyl-L-carnitine oxidation and CPT-II activity were, however, unchanged after either EPA treatment or starvation. The results from this study open the possibility that the rate control of mitochondrial beta-oxidation under mitochondrion and peroxisome proliferation is distributed between an enzyme or enzymes of the pathway beyond the CPT-I site after 3-thia fatty acid treatment. It is suggested that fatty acids are partly oxidized in the peroxisomes before entering the mitochondria as acylcarnitines for further oxidation.

Citing Articles

Meldonium-induced steatosis is associated with increased delta 6 desaturation and reduced elongation of n-6 polyunsaturated fatty acids.

Bjorndal B, Tungland S, Bohov P, Sydnes M, Dankel S, Madsen L Liver Res. 2025; 8(3):152-164.

PMID: 39957749 PMC: 11771272. DOI: 10.1016/j.livres.2024.09.001.


Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat.

Strand E, Bjorndal B, Nygard O, Burri L, Berge C, Bohov P Lipids Health Dis. 2012; 11:82.

PMID: 22738017 PMC: 3459737. DOI: 10.1186/1476-511X-11-82.


Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome.

Liaset B, Hao Q, Jorgensen H, Hallenborg P, Du Z, Ma T J Biol Chem. 2011; 286(32):28382-95.

PMID: 21680746 PMC: 3151081. DOI: 10.1074/jbc.M111.234732.


The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression.

Ukropec J, Reseland J, Gasperikova D, Demcakova E, Madsen L, Berge R Lipids. 2003; 38(10):1023-9.

PMID: 14669966 DOI: 10.1007/s11745-006-1156-z.

References
1.
McGarry J, Brown N . The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997; 244(1):1-14. DOI: 10.1111/j.1432-1033.1997.00001.x. View

2.
Clarke S, Baillie R, Jump D, Nakamura M . Fatty acid regulation of gene expression. Its role in fuel partitioning and insulin resistance. Ann N Y Acad Sci. 1997; 827:178-87. DOI: 10.1111/j.1749-6632.1997.tb51833.x. View

3.
Froyland L, Vaagenes H, Asiedu D, Garras A, Lie O, Berge R . Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs. Lipids. 1996; 31(2):169-78. DOI: 10.1007/BF02522617. View

4.
Madsen L, Froyland L, GRAV H, Berge R . Up-regulated delta 9-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: accumulation of a delta 9-desaturated metabolite of tetradecylthioacetic acid. J Lipid Res. 1997; 38(3):554-63. View

5.
Willumsen N, Hexeberg S, Skorve J, LUNDQUIST M, Berge R . Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res. 1993; 34(1):13-22. View